Time for enhancing government-led primary prevention of cervical cancer
Kyung‐Jin Min, Dong Hoon Suh, Tsukasa Baba, Xiaojun Chen, Jae‐Weon Kim, Yusuke Kobayashi, Janice S. Kwon, Myong Cheol Lim, Jung‐Yun Lee, Satoru Nagase, Jeong‐Yeol Park, Siriwan Tangjitgamol, Hidemichi Watari
Abstract
1/5 https://ejgo.org Cervical cancer is a preventable disease. Lei et al. [1] recently demonstrated using the Swedish nationwide registry that human papillomavirus (HPV) vaccines protected not only precancerous cervical lesions but also invasive cervical cancers. In this study, the risk of cervical cancer among women who had been vaccinated <17 years of age was 88% lower than the unvaccinated population. This effective vaccination results in a survival benefit when 'herd immunity' is achieved through high vaccination coverage in a population. One systematic review and meta-analysis by Drolet et al. Vaccine coverage of the study of Lei et al. This critical role of high vaccine coverage rates in reduction of cervical cancer incidence suggest that the HPV vaccination program must be scaled to national levels.